Pharmafile - Research and Development
Roche revealed strong data on its cancer immunotherapy Tecentriq in combination with chemotherapy in the first-line treatment of previously...
Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin...
MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, this time with...
Check out this week's top 10 stories at Pharmafile.com now!
Features
“It really is about having a dream and figuring out how to go about accomplishing that dream”
Appointments
Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen Chief Quality...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Events
Wednesday, July 3, 2019 - Friday, July 5, 2019
London, United Kingdom
Conference
After successfully organizing series of ipharma events...
